News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Monument Therapeutics Secures £1M Investment to Advance Schizophrenia Treatment...

Oct 21st 2024
Monument Therapeutics, a leader in precision neuroscience, has announced a significant £1 million equity investment from the Forster Foundation, a charitable organization.
Read More

Bionow’s inaugural 2024 Neuroscience conference showcases key developments acr...

Jul 18th 2024
The first ever Neuroscience conference, hosted in Sheffield, proved to be a great success with 115 delegates and eight exhibitors collaborating and exploring the current challenges and oppor...
Read More

Motor Neurone Disease Awareness Month: Durham spin-out given the go-ahead to tri...

Jun 26th 2024
June is Motor Neurone Disease (MND) Awareness Month. Andy Whiting, an Emeritus Professor in our Department of Chemistry and CEO of our spin-out company Nevrargenics Limited, explains how his...
Read More

Precision neuroscience company Monument Therapeutics announces £1.5m funding to...

Apr 22nd 2024
Monument Therapeutics, a precision neuroscience company, today announced new funding of £1.5 million from a combination of equity investment and non-dilutive grant as part of the Innovate U...
Read More

Researchers developing ultra-sensitive blood test with potential to revolutionis...

Apr 5th 2024
Researchers at the University of York are using light-based technology to develop a simple and cost-effective blood test for Alzheimer’s disease.
Read More

First UK-wide study of brain complications in patients with COVID-19

Jun 29th 2020
Researchers at the University of Liverpool have led the first nationwide surveillance study of the neurological complications of COVID-19.
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners